184 related articles for article (PubMed ID: 10871849)
1. Two arginine rich domains in the p14ARF tumour suppressor mediate nucleolar localization.
Rizos H; Darmanian AP; Mann GJ; Kefford RF
Oncogene; 2000 Jun; 19(26):2978-85. PubMed ID: 10871849
[TBL] [Abstract][Full Text] [Related]
2. Cooperative signals governing ARF-mdm2 interaction and nucleolar localization of the complex.
Weber JD; Kuo ML; Bothner B; DiGiammarino EL; Kriwacki RW; Roussel MF; Sherr CJ
Mol Cell Biol; 2000 Apr; 20(7):2517-28. PubMed ID: 10713175
[TBL] [Abstract][Full Text] [Related]
3. Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus.
Llanos S; Clark PA; Rowe J; Peters G
Nat Cell Biol; 2001 May; 3(5):445-52. PubMed ID: 11331871
[TBL] [Abstract][Full Text] [Related]
4. Nucleolar p14(ARF) overexpression in Reed-Sternberg cells in Hodgkin's lymphoma: absence of p14(ARF)/Hdm2 complexes is associated with expression of alternatively spliced Hdm2 transcripts.
García JF; Villuendas R; Sánchez-Beato M; Sánchez-Aguilera A; Sánchez L; Prieto I; Piris MA
Am J Pathol; 2002 Feb; 160(2):569-78. PubMed ID: 11839577
[TBL] [Abstract][Full Text] [Related]
5. Defining the molecular basis of Arf and Hdm2 interactions.
Bothner B; Lewis WS; DiGiammarino EL; Weber JD; Bothner SJ; Kriwacki RW
J Mol Biol; 2001 Nov; 314(2):263-77. PubMed ID: 11718560
[TBL] [Abstract][Full Text] [Related]
6. ARF function does not require p53 stabilization or Mdm2 relocalization.
Korgaonkar C; Zhao L; Modestou M; Quelle DE
Mol Cell Biol; 2002 Jan; 22(1):196-206. PubMed ID: 11739734
[TBL] [Abstract][Full Text] [Related]
7. Multiple interacting domains contribute to p14ARF mediated inhibition of MDM2.
Clark PA; Llanos S; Peters G
Oncogene; 2002 Jul; 21(29):4498-507. PubMed ID: 12085228
[TBL] [Abstract][Full Text] [Related]
8. Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53.
Zhang Y; Xiong Y
Mol Cell; 1999 May; 3(5):579-91. PubMed ID: 10360174
[TBL] [Abstract][Full Text] [Related]
9. DNA damage disrupts the p14ARF-B23(nucleophosmin) interaction and triggers a transient subnuclear redistribution of p14ARF.
Lee C; Smith BA; Bandyopadhyay K; Gjerset RA
Cancer Res; 2005 Nov; 65(21):9834-42. PubMed ID: 16267006
[TBL] [Abstract][Full Text] [Related]
10. Intrinsically unstructured domains of Arf and Hdm2 form bimolecular oligomeric structures in vitro and in vivo.
Sivakolundu SG; Nourse A; Moshiach S; Bothner B; Ashley C; Satumba J; Lahti J; Kriwacki RW
J Mol Biol; 2008 Dec; 384(1):240-54. PubMed ID: 18809412
[TBL] [Abstract][Full Text] [Related]
11. The Short N-Terminal Repeats of Transcription Termination Factor 1 Contain Semi-Redundant Nucleolar Localization Signals and P19-ARF Tumor Suppressor Binding Sites.
Boutin J; Lessard F; Tremblay MG; Moss T
Yale J Biol Med; 2019 Sep; 92(3):385-396. PubMed ID: 31543703
[TBL] [Abstract][Full Text] [Related]
12. Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function.
Korgaonkar C; Hagen J; Tompkins V; Frazier AA; Allamargot C; Quelle FW; Quelle DE
Mol Cell Biol; 2005 Feb; 25(4):1258-71. PubMed ID: 15684379
[TBL] [Abstract][Full Text] [Related]
13. Different effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 in vivo.
Xirodimas D; Saville MK; Edling C; Lane DP; Laín S
Oncogene; 2001 Aug; 20(36):4972-83. PubMed ID: 11526482
[TBL] [Abstract][Full Text] [Related]
14. Nucleolar Arf sequesters Mdm2 and activates p53.
Weber JD; Taylor LJ; Roussel MF; Sherr CJ; Bar-Sagi D
Nat Cell Biol; 1999 May; 1(1):20-6. PubMed ID: 10559859
[TBL] [Abstract][Full Text] [Related]
15. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.
Stott FJ; Bates S; James MC; McConnell BB; Starborg M; Brookes S; Palmero I; Ryan K; Hara E; Vousden KH; Peters G
EMBO J; 1998 Sep; 17(17):5001-14. PubMed ID: 9724636
[TBL] [Abstract][Full Text] [Related]
16. Stability of nucleolar versus non-nucleolar forms of human p14(ARF).
Rodway H; Llanos S; Rowe J; Peters G
Oncogene; 2004 Aug; 23(37):6186-92. PubMed ID: 15286709
[TBL] [Abstract][Full Text] [Related]
17. p14ARF is a component of the p53 response following ionizing irradiation of normal human fibroblasts.
Khan S; Guevara C; Fujii G; Parry D
Oncogene; 2004 Aug; 23(36):6040-6. PubMed ID: 15195142
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation.
Lin AW; Lowe SW
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5025-30. PubMed ID: 11309506
[TBL] [Abstract][Full Text] [Related]
19. Contribution of two independent MDM2-binding domains in p14(ARF) to p53 stabilization.
Lohrum MA; Ashcroft M; Kubbutat MH; Vousden KH
Curr Biol; 2000 May; 10(9):539-42. PubMed ID: 10801444
[TBL] [Abstract][Full Text] [Related]
20. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways.
Zhang Y; Xiong Y; Yarbrough WG
Cell; 1998 Mar; 92(6):725-34. PubMed ID: 9529249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
